ASX - By Stock
|
RCE |
Re:
Ann: Positive Ph I/II DFI Efficacy Data to Support Site Expansion
|
|
Stecam44
|
34 |
13K |
1 |
18/01/24 |
18/01/24 |
ASX - By Stock
|
34
|
13K
|
1
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Trading Halt
|
|
Stecam44
|
66 |
18K |
0 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
66
|
18K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Trading Halt
|
|
Stecam44
|
66 |
18K |
0 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
66
|
18K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Trading Halt
|
|
Stecam44
|
66 |
18K |
0 |
10/09/23 |
10/09/23 |
ASX - By Stock
|
66
|
18K
|
0
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Trading Halt
|
|
Stecam44
|
66 |
18K |
4 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
66
|
18K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Opening R&D Address at World AMR Congress
|
|
Stecam44
|
6 |
2.6K |
9 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
6
|
2.6K
|
9
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Appendix 4E and Unaudited Preliminary Report
|
|
Stecam44
|
20 |
6.6K |
4 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
20
|
6.6K
|
4
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Stecam44
|
45 |
13K |
9 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
45
|
13K
|
9
|
|